Product
Transplant, Autologous
1 clinical trial
2 indications
Indication
Multiple MyelomaIndication
MRDClinical trial
Comparing the Efficacy and Safety of Autologous Hematopoietic Stem-cell Transplantation Versus Non Transplantation Regimen in Primary Multiple Myeloma Achieved MRD Negativity After Induction: A Multiple Center, Prospective Cohort StudyStatus: Recruiting, Estimated PCD: 2028-11-01